- Home
- AKRO vs RNST Comparison
AKRO vs RNST Comparison
Compare AKRO & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- RNST
- Stock Information
- Founded
- AKRO 2017
- RNST 1904
- Country
- AKRO United States
- RNST United States
- Employees
- AKRO N/A
- RNST N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- RNST Major Banks
- Sector
- AKRO Health Care
- RNST Finance
- Exchange
- AKRO Nasdaq
- RNST Nasdaq
- Market Cap
- AKRO 3.9B
- RNST 3.3B
- IPO Year
- AKRO 2019
- RNST N/A
- Fundamental
- Price
- AKRO $51.41
- RNST $37.17
- Analyst Decision
- AKRO Strong Buy
- RNST Buy
- Analyst Count
- AKRO 6
- RNST 6
- Target Price
- AKRO $82.50
- RNST $42.20
- AVG Volume (30 Days)
- AKRO 1.8M
- RNST 549.7K
- Earning Date
- AKRO 08-08-2025
- RNST 07-22-2025
- Dividend Yield
- AKRO N/A
- RNST 2.37%
- EPS Growth
- AKRO N/A
- RNST 31.26
- EPS
- AKRO N/A
- RNST 3.20
- Revenue
- AKRO N/A
- RNST $710,265,000.00
- Revenue This Year
- AKRO N/A
- RNST $40.84
- Revenue Next Year
- AKRO N/A
- RNST $13.45
- P/E Ratio
- AKRO N/A
- RNST $11.58
- Revenue Growth
- AKRO N/A
- RNST 15.97
- 52 Week Low
- AKRO $21.02
- RNST $26.97
- 52 Week High
- AKRO $58.40
- RNST $39.63
- Technical
- Relative Strength Index (RSI)
- AKRO 47.91
- RNST 64.36
- Support Level
- AKRO $53.05
- RNST $35.58
- Resistance Level
- AKRO $57.35
- RNST $36.57
- Average True Range (ATR)
- AKRO 2.45
- RNST 0.73
- MACD
- AKRO -0.64
- RNST 0.10
- Stochastic Oscillator
- AKRO 4.65
- RNST 89.67
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.